Literature DB >> 1650011

Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: modulation by neutral endopeptidase.

N Sakai1, J Tamaoki, K Kobayashi, T Kanemura, K Isono, K Takeyama, S Takeuchi, T Takizawa.   

Abstract

We studied the effect of vasoactive intestinal peptide (VIP) on ciliary activity in rabbit cultured tracheal epithelium by a photoelectric method in vitro. Administration of VIP (10(-7) M) elicited an increase in ciliary beat frequency (CBF) from the baseline values of 970 +/- 52 to 1139 +/- 75 beats/min (mean +/- S.E., P less than 0.01). This ciliostimulatory effect was dose-dependent, with the maximal increase and EC50 value being 17.4 +/- 1.0% (P less than 0.05) and 6.10(-11) M, respectively. The VIP-induced increase in CBF was abolished by pretreatment of cells with [4-Cl-D-Phe6, Leu17]-VIP, a VIP receptor antagonist. The neutral endopeptidase inhibitor phosphoramidon (10(-5) M) potentiated the effect of VIP, so that the CBF dose-response curve for VIP was shifted to lower concentrations by 0.5 log U. The administration of VIP increased cyclic AMP levels in epithelial cells, an effect that was also potentiated by phosphoramidon. These results suggest that VIP may interact with its specific receptors and stimulate airway ciliary activity probably through the activation of adenylate cyclase, and that neutral endopeptidase may play a role in modulating this effect of VIP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650011     DOI: 10.1016/0167-0115(91)90222-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

1.  Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Regul Pept       Date:  2010-06-08

2.  The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma.

Authors:  A E Samarasinghe; S A Hoselton; J M Schuh
Journal:  Peptides       Date:  2010-03-11       Impact factor: 3.750

3.  Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.

Authors:  A Lindén; L Hansson; A Andersson; M Palmqvist; P Arvidsson; C-G Löfdahl; P Larsson; J Lötvall
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

4.  Epithelium-dependent effect of L-glutamate on airways: involvement of prostaglandins.

Authors:  Apostolia A Hatziefthimiou; Konstantinos I Gourgoulianis; Paschalis-Adam Molyvdas
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.